Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Intranasal Ketamine Use in Autism Spectrum Disorder: A Placebo-Controlled Crossover Pilot Study


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02611921

Organisation Name: Children's Hospital Medical Center, Cincinnati

Overal Status: Completed

Start Date: December 22, 2015

Last Update: October 12, 2018

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Brief Summary: The purpose of the study is to determine if intranasal ketamine shows initial evidence of safety, tolerability and efficacy for the treatment of social impairment in individuals with Autism Spectrum Disorder.

Conditions:
  • Autism Spectrum Disorder


Total execution time in seconds: 0.20103597640991